This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open AccessArticle
Enhanced In Vitro Efficacy of Verbascoside in Suppressing Hepatic Stellate Cell Activation via ROS Scavenging with Reverse Microemulsion
by
Xiao Xiao
Xiao Xiao 1,2,†,
Feiyu Yang
Feiyu Yang 1,3,†,
Yuling Huang
Yuling Huang 4,
Shaohui Liu
Shaohui Liu 1,2,
Zhenhua Hu
Zhenhua Hu 2,5,
Shanggao Liao
Shanggao Liao 1,3,* and
Yuanyuan Li
Yuanyuan Li 1,2,4,6,7,*
1
School of Pharmacy, Guizhou Medical University, Guiyang 550025, China
2
Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528400, China
3
University Engineering Research Center for the Prevention and Treatment of Chronic Diseases by Authentic Medicinal Materials in Guizhou Province & School of Pharmacy, Guiyang 550025, China
4
School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China
5
Department of Health and Nursing, Nanfang College of Sun Yat-sen University, Guangzhou 510970, China
6
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
7
University of Chinese Academy of Sciences, Beijing 100049, China
*
Authors to whom correspondence should be addressed.
†
These authors contribute equally to this work.
Antioxidants 2024, 13(8), 907; https://doi.org/10.3390/antiox13080907 (registering DOI)
Submission received: 18 June 2024
/
Revised: 25 July 2024
/
Accepted: 26 July 2024
/
Published: 27 July 2024
Abstract
Abstract: Numerous approaches targeting hepatic stellate cells (HSCs) have emerged as pivotal therapeutic strategies to mitigate liver fibrosis and are currently undergoing clinical trials. The investigation of herbal drugs or isolated natural active compounds is particularly valuable, due to their multifaceted functions and low risk of side effects. Recent studies have hinted at the potential efficacy of verbascoside (VB) in ameliorating renal and lung fibrosis, yet its impact on hepatic fibrosis remains to be elucidated. This study aims to evaluate the potential effects of VB on liver fibrosis by assessing its ability to inhibit HSC activation. VB demonstrated significant efficacy in suppressing the expression of fibrogenic genes in activated LX-2 cells. Additionally, VB inhibited the migration and proliferation of these activated HSCs by scavenging reactive oxygen species (ROS) and downregulating the AMPK pathway. Furthermore, a biosafe reverse microemulsion loaded with VB (VB-ME) was developed to improve VB’s instability and low bioavailability. The optimal formulation of VB-ME was meticulously characterized, revealing substantial enhancements in cellular uptake, ROS-scavenging capacity, and the suppression of HSC activation.
Share and Cite
MDPI and ACS Style
Xiao, X.; Yang, F.; Huang, Y.; Liu, S.; Hu, Z.; Liao, S.; Li, Y.
Enhanced In Vitro Efficacy of Verbascoside in Suppressing Hepatic Stellate Cell Activation via ROS Scavenging with Reverse Microemulsion. Antioxidants 2024, 13, 907.
https://doi.org/10.3390/antiox13080907
AMA Style
Xiao X, Yang F, Huang Y, Liu S, Hu Z, Liao S, Li Y.
Enhanced In Vitro Efficacy of Verbascoside in Suppressing Hepatic Stellate Cell Activation via ROS Scavenging with Reverse Microemulsion. Antioxidants. 2024; 13(8):907.
https://doi.org/10.3390/antiox13080907
Chicago/Turabian Style
Xiao, Xiao, Feiyu Yang, Yuling Huang, Shaohui Liu, Zhenhua Hu, Shanggao Liao, and Yuanyuan Li.
2024. "Enhanced In Vitro Efficacy of Verbascoside in Suppressing Hepatic Stellate Cell Activation via ROS Scavenging with Reverse Microemulsion" Antioxidants 13, no. 8: 907.
https://doi.org/10.3390/antiox13080907
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details
here.
Article Metrics
Article metric data becomes available approximately 24 hours after publication online.